Old Web
English
Sign In
Acemap
>
authorDetail
>
Khuda Khan
Khuda Khan
National Foundation for Cancer Research
Medicine
Pathology
Phases of clinical research
Refractory
Temozolomide
3
Papers
91
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase I Study of Temozolomide and Laromustine (VNP40101M) in Patients With Relapsed or Refractory Leukemia
2010
Clinical Lymphoma, Myeloma & Leukemia
David A. Rizzieri
Samantha LoRusso
William Tse
Khuda Khan
Anjali S. Advani
Joseph O. Moore
Verena Karsten
Ann Cahill
Stanton L. Gerson
Show All
Source
Cite
Save
Citations (8)
Cloretazine (VNP40101M), a Novel Sulfonylhydrazine Alkylating Agent, in Patients Age 60 Years or Older With Previously Untreated Acute Myeloid Leukemia
2006
Journal of Clinical Oncology
Francis J. Giles
David A. Rizzieri
Judith E. Karp
Norbert Vey
Farhad Ravandi
Stefan Faderl
Khuda Khan
Gregor Verhoef
Pierre W. Wijermans
Anjali S. Advani
Gail J. Roboz
Hagop M. Kantarjian
Syed Fazl Ali Bilgrami
Augustin Ferrant
Simon Daenen
Verena Karsten
Ann Cahill
Maher Albitar
Ghulam J. Mufti
Susan OBrien
Show All
Source
Cite
Save
Citations (80)
Phase II study of VNP40101M in patients (pts) with acute myelogenous leukemia (AML) and high-risk myelodysplasia (MDS)
2005
Journal of Clinical Oncology
F. Giles
S. OBrien
Norbert Vey
Eric J. Feldman
David A. Rizzieri
Khuda Khan
Syed Fazl Ali Bilgrami
Gregor Verhoef
Ghulam J. Mufti
Bonny Johnson
Judith E. Karp
Show All
Source
Cite
Save
Citations (3)
1